Charles A. Rowland Jr., VP, Chief Financial Officer at VIROPHARMA INC (VPHM), sold 82,750 shares at $32.12 ($2.7M) on 2012-03-01, disclosed to the SEC on 2012-03-05.
Open-market sale of $2.7M VPHM by VP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.11 | 12,750 | $409K | 15.4% |
| 2 | $32.12 | 70,000 | $2.2M | 84.6% |
| Total | $32.12 avg | 82,750 | $2.7M | 100% |
| Filing → |
| VKTX | SELL | 2023-05-18 | $1.0M | — | Filing → |
| GBIO | BUY | 2022-09-20 | $83K | — | Filing → |
| GBIO | BUY | 2022-09-19 | $552K | — | Filing → |